<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Can J Anaesth</journal-id>
      <journal-title-group>
        <journal-title>Canadian Journal of Anaesthesia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0832-610X</issn>
      <issn pub-type="epub">1496-8975</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20461490</article-id>
      <article-id pub-id-type="pmc">2899019</article-id>
      <article-id pub-id-type="publisher-id">9325</article-id>
      <article-id pub-id-type="doi">10.1007/s12630-010-9325-1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Reports of Original Investigations</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Morphine induces preconditioning via activation of mitochondrial K<sub>Ca</sub> channels</article-title>
        <trans-title-group>
          <trans-title xml:lang="fr">La morphine provoque le pr&#xE9;conditionnement par l&#x2019;activation des canaux mitochondriaux K<sub>Ca</sub></trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fr&#xE4;&#xDF;dorf</surname>
            <given-names>Jan</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Huhn</surname>
            <given-names>Ragnar</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <address>
            <phone>+49 (0)211-81-18101</phone>
            <fax>+49 (0)211-81-16253</fax>
            <email>Ragnar.Huhn@med.uni-duesseldorf.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Niersmann</surname>
            <given-names>Corinna</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weber</surname>
            <given-names>Nina C.</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schlack</surname>
            <given-names>Wolfgang</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Preckel</surname>
            <given-names>Benedikt</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hollmann</surname>
            <given-names>Markus W.</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Anesthesiology, Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>University Hospital, Duesseldorf, Germany </aff>
        <aff id="Aff3"><label>3</label>Department of Anesthesiology, University Hospital Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>5</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>12</day>
        <month>5</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2010</year>
      </pub-date>
      <volume>57</volume>
      <issue>8</issue>
      <fpage>767</fpage>
      <lpage>773</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>2</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>4</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2010</copyright-statement>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>Mitochondrial calcium sensitive potassium (mK<sub>Ca</sub>) channels are involved in cardioprotection induced by ischemic preconditioning. In the present study we investigated whether morphine-induced preconditioning also involves activation of mK<sub>Ca</sub> channels.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Isolated rat hearts (six groups; each <italic>n</italic>&#xA0;=&#xA0;8) underwent global ischemia for 30&#xA0;min followed by a 60-min reperfusion. Control animals were not further treated. Morphine preconditioning (MPC) was initiated by two five-minute&#xA0;cycles of morphine 1&#xA0;&#x3BC;M infusion with one five-minute washout and one final ten-minute washout period before ischemia. The mK<sub>Ca</sub> blocker, paxilline 1&#xA0;&#x3BC;M, was administered, with and without morphine administration (MPC&#xA0;+&#xA0;Pax and Pax). As a positive control, we added an ischemic preconditioning group (IPC) alone and combined with paxilline (IPC&#xA0;+&#xA0;Pax). At the end of reperfusion, infarct sizes were determined by triphenyltetrazoliumchloride staining.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Infarct size was (mean&#xA0;&#xB1;&#xA0;SD) 45&#xA0;&#xB1;&#xA0;9% of the area at risk in the Control group. The infarct size was less in the morphine or ischemic preconditioning groups (MPC: 23&#xA0;&#xB1;&#xA0;8%, IPC: 20&#xA0;&#xB1;&#xA0;5%; each <italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> Control). Infarct size reduction was abolished by paxilline (MPC&#xA0;+&#xA0;Pax: 37&#xA0;&#xB1;&#xA0;7%, <italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> MPC and IPC&#xA0;+&#xA0;Pax: 36&#xA0;&#xB1;&#xA0;6%, <italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> IPC), whereas paxilline alone had no effect (Pax: 46&#xA0;&#xB1;&#xA0;7%, not significantly different from Control).</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Cardioprotection by morphine-induced preconditioning is mediated by activation of mK<sub>Ca</sub> channels.</p>
        </sec>
      </abstract>
      <trans-abstract xml:lang="fr">
        <title>R&#xE9;sum&#xE9;</title>
        <sec>
          <title>Objectif&#xA0;</title>
          <p>Les canaux potassiques mitochondriaux calcium-d&#xE9;pendants (mK<sub>Ca</sub>) participent &#xE0; la cardioprotection induite par le pr&#xE9;conditionnement isch&#xE9;mique. Dans la pr&#xE9;sente &#xE9;tude, nous avons tent&#xE9; de d&#xE9;couvrir si le pr&#xE9;conditionnement provoqu&#xE9; par la morphine implique &#xE9;galement l&#x2019;activation des canaux mK<sub>Ca</sub>.</p>
        </sec>
        <sec>
          <title>M&#xE9;thodes&#xA0;</title>
          <p>Des c&#x153;urs isol&#xE9;s de rats (six groupes; chacun de <italic>n</italic>&#xA0;=&#xA0;8) ont &#xE9;t&#xE9; soumis &#xE0; une isch&#xE9;mie globale pendant 30&#xA0;min, suivie d&#x2019;une perfusion de 60&#xA0;min. Les animaux t&#xE9;moins n&#x2019;ont re&#xE7;u aucun autre traitement. Le pr&#xE9;conditionnement provoqu&#xE9; par la morphine (MPC) a &#xE9;t&#xE9; initi&#xE9; par deux cycles de cinq minutes d&#x2019;une perfusion de morphine &#xE0; 1&#xA0;&#x3BC;M, avec une p&#xE9;riode de rin&#xE7;age de cinq minutes et une p&#xE9;riode de rin&#xE7;age finale de dix minutes avant l&#x2019;isch&#xE9;mie. L&#x2019;inhibiteur des canaux mK<sub>Ca</sub>, la paxilline &#xE0; 1 &#x3BC;M, a &#xE9;t&#xE9; administr&#xE9;, avec ou sans administration de morphine (MPC&#xA0;+&#xA0;Pax et Pax). &#xC0; titre de valeur t&#xE9;moin positive, nous avons ajout&#xE9; un groupe soumis &#xE0; un pr&#xE9;conditionnement isch&#xE9;mique (IPC) seul et combin&#xE9; &#xE0; la paxilline (IPC&#xA0;+&#xA0;Pax). &#xC0; la fin de la reperfusion, la taille de chaque infarctus a &#xE9;t&#xE9; d&#xE9;termin&#xE9;e par la coloration du chlorure de tryph&#xE9;nylt&#xE9;trazolium.</p>
        </sec>
        <sec>
          <title>R&#xE9;sultats&#xA0;</title>
          <p>La taille de l&#x2019;infarctus couvrait 45&#xA0;&#xB1;&#xA0;9&#xA0;% (moyenne&#xA0;&#xB1;&#xA0;&#xE9;cart type) de la zone &#xE0; risque dans le groupe t&#xE9;moin. La taille de l&#x2019;infarctus &#xE9;tait moins importante dans les groupes ayant re&#xE7;u de la morphine ou ayant subi un pr&#xE9;conditionnement isch&#xE9;mique (MPC: 23&#xA0;&#xB1;&#xA0;8&#xA0;%, IPC: 20&#xA0;&#xB1;&#xA0;5&#xA0;%; chacun de <italic>P</italic>&#xA0;&lt;&#xA0;0,05 <italic>contre</italic> le groupe t&#xE9;moin). L&#x2019;effet de r&#xE9;duction de la taille de l&#x2019;infarctus a &#xE9;t&#xE9; &#xE9;limin&#xE9; par la paxilline (MPC&#xA0;+&#xA0;Pax: 37&#xA0;&#xB1;&#xA0;7&#xA0;%, <italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>contre</italic> MPC et IPC&#xA0;+&#xA0;Pax: mi,que (MPC&#xA0;&#xB1;&#xA0;6&#xA0;%, <italic>P</italic>&#xA0;&lt;&#xA0;0,05 <italic>contre</italic> IPC), tandis qu&#x2019;administr&#xE9;e seule, la paxilline n&#x2019;a eu aucun effet (Pax: 46&#xA0;&#xB1;&#xA0;7&#xA0;%, aucune diff&#xE9;rence notable comparativement au groupe t&#xE9;moin).</p>
        </sec>
        <sec>
          <title>Conclusion&#xA0;</title>
          <p>La cardioprotection par pr&#xE9;conditionnement provoqu&#xE9; par la morphine est assist&#xE9;e par l&#x2019;activation des canaux mK<sub>Ca</sub>.</p>
        </sec>
      </trans-abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Morphine</kwd>
        <kwd>Preconditioning</kwd>
        <kwd>mKCa</kwd>
        <kwd>Infarct size</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Canadian Anesthesiologists' Society 2010</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Cardioprotection by preconditioning can be induced by various stimuli, such as brief cycles of ischemia or pharmacological agents, including volatile anesthetics and morphine<xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref>. Both ischemic and morphine preconditioning protect the heart by sharing common cellular pathways. Opening of mitochondrial ATP-sensitive potassium (mK<sub>ATP</sub>) channels is involved in regulation of mitochondrial functions, representing a key step in mediating the cardioprotective effects of ischemic- and morphine-induced preconditioning, possibly due to inhibition of mitochondrial permeability transition pore (mPTP).<xref ref-type="bibr" rid="CR3">3</xref>-<xref ref-type="bibr" rid="CR5">5</xref> Besides opening of mK<sub>ATP</sub> channels, activation of the mitochondrial calcium sensitive potassium (mK<sub>Ca</sub>) channel is also involved in preconditioning.<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref> Cao <italic>et al.</italic> demonstrated that activation of mK<sub>Ca</sub> channels plays a crucial role in ischemic preconditioning and that cardioprotection, by activation of mK<sub>Ca</sub> channels, is independent of mK<sub>ATP</sub> channels and vice versa.<xref ref-type="bibr" rid="CR8">8</xref> In another study, the same authors demonstrated that preconditioning by activation of &#x3BA;-opioid receptors is triggered by mK<sub>Ca</sub> channels.<xref ref-type="bibr" rid="CR9">9</xref> However, the opioid, morphine, is predominantly a &#x3BC;-receptor agonist and has only a low affinity for &#x3BA;-opioid receptors.<xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref> Furthermore, there is no &#x3BA;-opioid agonist for clinical practice available. It is not known whether activation of mK<sub>Ca</sub> channels is involved in morphine-induced preconditioning. The purpose of the present study was to test the hypothesis that morphine-induced preconditioning is mediated by activation of mK<sub>Ca</sub> channels.</p>
    <sec id="Sec1" sec-type="methods">
      <title>Methods</title>
      <p>The investigation conforms to the <italic>Guide for the Care and Use of Laboratory Animals</italic> published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was performed in accordance with the requirements of the Animal Ethics Committee of the University of Duesseldorf, Duesseldorf, Germany.</p>
      <sec id="Sec2">
        <title>Chemicals and reagents</title>
        <p>All chemicals were purchased from Sigma-Aldrich (Taufkirchen, Germany).</p>
      </sec>
      <sec id="Sec3">
        <title>Surgical preparation</title>
        <p>Male Wistar rats were used for these studies. The rats were maintained on a 12:12 light/dark schedule (lights on at 0600&#xA0;hr) with food and water provided <italic>ad libitum</italic>. The animals were anesthetized with pentobarbital 90&#xA0;mg&#xA0;&#xB7;&#xA0;kg<sup>&#x2212;1</sup><italic>ip</italic>. After thoracotomy, the hearts were excised, mounted on a Langendorff system, and perfused at constant pressure (80&#xA0;mmHg) with Krebs&#x2013;Henseleit solution containing (in mM) 116 NaCl, 4.7 KCl, 1.1 MgSO<sub>4</sub>, 1.17 KH<sub>2</sub>PO<sub>4</sub>, 24.9 NaHCO<sub>3</sub>, 2.52 CaCl<sub>2</sub>, 8.3 glucose, and 2.2 pyruvate at 37&#xB0;C. A fluid-filled balloon was inserted into the left ventricle, and end-diastolic pressure was set at 1-4&#xA0;mmHg. All hearts underwent a stabilization period of 20&#xA0;min. Heart rate (HR), myocardial function (isovolumetric left ventricular pressure), coronary flow, left ventricular end-diastolic pressure, and rate of left ventricular pressure development (dP/dt<sub>max</sub>) were measured continuously. The data were digitized using an analogue to digital converter (PowerLab/8SP, ADInstruments Pty Ltd, Castle Hill, Australia) at a sampling rate of 500&#xA0;Hz, and they were recorded continuously on a personal computer using Chart for Windows v5.0 (ADInstruments). Maximal contracture and time to maximal contracture were noted during ischemia. Arrhythmic intervals were not used for data analysis.</p>
      </sec>
      <sec id="Sec4">
        <title>Experimental protocol for infarct size determination</title>
        <p>The hearts were assigned randomly to one of six experimental groups (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The hearts of all groups underwent 30&#xA0;min of ischemia followed by 60&#xA0;min of reperfusion. In the control group (Con), the hearts were kept under baseline conditions prior to ischemia. To investigate whether morphine induces preconditioning (MPC), morphine 1&#xA0;&#x3BC;M was given in two five-minute cycles, separated by one five-minute washout period, and ending with one final ten-minute washout period prior to ischemia. The morphine concentration was chosen because Liang <italic>et al</italic>. demonstrated that the preconditioning effect of morphine was maximal at 1 &#x3BC;M.<xref ref-type="bibr" rid="CR12">12</xref> Morphine was dissolved in 0.9% NaCl and separately infused into a mixing chamber placed in the perfusion system. As a positive control, the ischemic preconditioning group (IPC) underwent two similar&#xA0;five-minute cycles of ischemia ten minutes prior to ischemia. To test whether mK<sub>Ca</sub> channels are involved in the phenomenon of preconditioning, the mK<sub>Ca</sub> channel inhibitor, paxilline 1&#xA0;&#x3BC;M,<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref> was given over 25&#xA0;min together with morphine- and ischemic-induced preconditioning (MPC&#xA0;+&#xA0;Pax and IPC&#xA0;+&#xA0;Pax). To rule out an effect of paxilline itself, we investigated the effect of paxilline alone (Pax).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Experimental protocol. IPC&#xA0;=&#xA0;ischemic preconditioning; MPC&#xA0;=&#xA0;morphine preconditioning; Pax&#xA0;=&#xA0;paxilline</p></caption><graphic xlink:href="12630_2010_9325_Fig1_HTML" id="MO1"/></fig></p>
        <p>After 60&#xA0;min of reperfusion, the heart was cut into transverse slices, which were then stained with 0.75% triphenyltetrazoliumchloride solution. The infarcted area was determined by planimetry using SigmaScan Pro 5&#xAE; computer software (SPSS Science Software, Chicago, IL, USA).</p>
      </sec>
      <sec id="Sec5">
        <title>Statistical analysis</title>
        <p>The sample size was calculated using GraphPad StatMate&#x2122; Version 1.01 (GraphPad Software, San Diego, CA, USA). Sample size analysis revealed that a group size of n&#xA0;=&#xA0;8 was necessary to detect a difference in infarct size of 25% with a power of 80% and an &#x3B1;&#xA0;&lt;&#xA0;0.05. The estimations of the mean difference of 25% and the standard deviation (SD) of 15% were based on our own data.<xref ref-type="bibr" rid="CR13">13</xref> Data are expressed as mean&#xA0;&#xB1;&#xA0;SD. Heart rate (in min<sup>&#x2212;1</sup>) and mean aortic pressure (in mmHg) were measured during baseline, coronary artery occlusion, and reperfusion period. Comparisons of hemodynamics between groups or between time points in a group were performed (SPSS Science Software, version 12.0.1) using two-way analysis of variance followed by Dunnett&#x2019;s post hoc test. A researcher blinded to the experimental groups determined the infarct sizes. The infarcts were analyzed by Student&#x2019;s <italic>t</italic> test followed by Bonferroni&#x2019;s correction for multiple comparisons. Changes within and among groups were considered statistically significant if <italic>P</italic>&#xA0;&lt;&#xA0;0.05.</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Results</title>
      <p>No differences in body or heart weight were observed between the groups (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). In the preconditioning groups, the level of maximal ischemic contracture was significantly lower, and the time of maximal ischemic contracture was significantly higher compared with the Control group (<italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> Con) (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Weights and ischemic contracture</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Body weight (g)</th><th align="left">Heart weight wet (g)</th><th align="left">Heart weight dry (mg)</th><th align="left">Maximal ischemic contracture (mmHg)</th><th align="left">Time of maximal. ischemic contracture (min)</th></tr></thead><tbody><tr><td align="left">Control</td><td char="&#xB1;" align="char">310&#xA0;&#xB1;&#xA0;25</td><td char="&#xB1;" align="char">1.5&#xA0;&#xB1;&#xA0;0.2</td><td char="&#xB1;" align="char">171&#xA0;&#xB1;&#xA0;17</td><td char="&#xB1;" align="char">36&#xA0;&#xB1;&#xA0;3</td><td char="&#xB1;" align="char">14&#xA0;&#xB1;&#xA0;1</td></tr><tr><td align="left">IPC</td><td char="&#xB1;" align="char">315&#xA0;&#xB1;&#xA0;23</td><td char="&#xB1;" align="char">1.5&#xA0;&#xB1;&#xA0;0.2</td><td char="&#xB1;" align="char">175&#xA0;&#xB1;&#xA0;18</td><td char="&#xB1;" align="char">20&#xA0;&#xB1;&#xA0;2*</td><td char="&#xB1;" align="char">27&#xA0;&#xB1;&#xA0;1*</td></tr><tr><td align="left">IPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">315&#xA0;&#xB1;&#xA0;24</td><td char="&#xB1;" align="char">1.5&#xA0;&#xB1;&#xA0;0.2</td><td char="&#xB1;" align="char">181&#xA0;&#xB1;&#xA0;17</td><td char="&#xB1;" align="char">39&#xA0;&#xB1;&#xA0;3</td><td char="&#xB1;" align="char">15&#xA0;&#xB1;&#xA0;3</td></tr><tr><td align="left">MPC</td><td char="&#xB1;" align="char">309&#xA0;&#xB1;&#xA0;26</td><td char="&#xB1;" align="char">1.5&#xA0;&#xB1;&#xA0;0.1</td><td char="&#xB1;" align="char">180&#xA0;&#xB1;&#xA0;20</td><td char="&#xB1;" align="char">20&#xA0;&#xB1;&#xA0;2*</td><td char="&#xB1;" align="char">27&#xA0;&#xB1;&#xA0;1*</td></tr><tr><td align="left">MPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">313&#xA0;&#xB1;&#xA0;27</td><td char="&#xB1;" align="char">1.5&#xA0;&#xB1;&#xA0;0.1</td><td char="&#xB1;" align="char">185&#xA0;&#xB1;&#xA0;19</td><td char="&#xB1;" align="char">39&#xA0;&#xB1;&#xA0;3</td><td char="&#xB1;" align="char">13&#xA0;&#xB1;&#xA0;2</td></tr><tr><td align="left">Pax</td><td char="&#xB1;" align="char">312&#xA0;&#xB1;&#xA0;25</td><td char="&#xB1;" align="char">1.6&#xA0;&#xB1;&#xA0;0.2</td><td char="&#xB1;" align="char">184&#xA0;&#xB1;&#xA0;19</td><td char="&#xB1;" align="char">36&#xA0;&#xB1;&#xA0;3</td><td char="&#xB1;" align="char">15&#xA0;&#xB1;&#xA0;1</td></tr></tbody></table><table-wrap-foot><p>Data are mean&#xA0;&#xB1;&#xA0;SD</p><p>IPC&#xA0;=&#xA0;ischemic preconditioning; MPC&#xA0;=&#xA0;morphine preconditioning; Pax&#xA0;=&#xA0;paxilline; *&#xA0;<italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> Control</p></table-wrap-foot></table-wrap></p>
      <sec id="Sec7">
        <title>Infarct size measurement</title>
        <p>In the Control group, infarct size was (mean&#xA0;&#xB1;&#xA0;SD) 45&#xA0;&#xB1;&#xA0;9% of the area at risk (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). In the ischemic- and morphine-induced preconditioning groups, infarct size was similar and significantly less than in the Control group (IPC: 20&#xA0;&#xB1;&#xA0;5%, MPC: 23&#xA0;&#xB1;&#xA0;8%; each <italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> Con) (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). The preconditioning effect of ischemia and morphine was attenuated significantly by the mK<sub>Ca</sub>-channel inhibitor, paxilline. Infarct size was 36&#xA0;&#xB1;&#xA0;6% and 37&#xA0;&#xB1;&#xA0;7% in the IPC&#xA0;+&#xA0;Pax and MPC&#xA0;+&#xA0;Pax groups, respectively; each <italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> IPC and MPC, respectively (Figure&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Paxilline alone had no effect on infarct size (Pax: 46&#xA0;&#xB1;&#xA0;7%; not significantly different from Con). There was no significant difference in infarct size between the preconditioning groups with paxilline compared with the Control group.<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Infarct size measurement. Histogram showing the infarct size (IS) as percent of area at risk (AAR) in Controls (Con, <italic>n</italic>&#xA0;=&#xA0;8), morphine preconditioning (MPC, <italic>n</italic>&#xA0;=&#xA0;8), ischemic preconditioning (IPC, <italic>n</italic>&#xA0;=&#xA0;8), morphine preconditioning with paxilline (MPC&#xA0;+&#xA0;Pax, <italic>n</italic>&#xA0;=&#xA0;8), ischemic preconditioning with paxilline (IPC&#xA0;+&#xA0;Pax, <italic>n</italic>&#xA0;=&#xA0;8), and paxilline alone (Pax, <italic>n</italic>&#xA0;=&#xA0;8). Data are mean&#xA0;&#xB1;&#xA0;SD; *&#xA0;<italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> Con; #&#xA0;<italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> IPC; &#xA7;&#xA0;<italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> MPC</p></caption><graphic xlink:href="12630_2010_9325_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec8">
        <title>Hemodynamic variables</title>
        <p>Hemodynamic variables are summarized in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>. No significant differences in left ventricular end-diastolic pressure and dP/dt<sub>max</sub> were observed between the experimental groups during baseline conditions and at the beginning of ischemia (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). At the end of the experiment, dP/dt<sub>max</sub> was higher in the preconditioning groups (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). There was no difference in HR compared with Controls at baseline and during reperfusion, with the exception of the paxilline group at time point final ten-minute washout shortly before index ischemia (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Hemodynamic variables</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">&#xA0;</th><th align="left">Baseline</th><th align="left">Washout 2</th><th align="left" colspan="4">Time after reperfusion (min)</th></tr><tr><th align="left"/><th align="left"/><th align="left">3</th><th align="left">15</th><th align="left">30</th><th align="left">60</th></tr></thead><tbody><tr><td align="left" colspan="7"><italic>Heart rate (min</italic><sup><italic>&#x2212;1</italic></sup>)</td></tr><tr><td align="left">Control</td><td char="&#xB1;" align="char">366&#xA0;&#xB1;&#xA0;37</td><td char="&#xB1;" align="char">359&#xA0;&#xB1;&#xA0;35</td><td char="&#xB1;" align="char">365&#xA0;&#xB1;&#xA0;29</td><td char="&#xB1;" align="char">378&#xA0;&#xB1;&#xA0;5</td><td char="&#xB1;" align="char">372&#xA0;&#xB1;&#xA0;15</td><td char="&#xB1;" align="char">373&#xA0;&#xB1;&#xA0;14</td></tr><tr><td align="left">IPC</td><td char="&#xB1;" align="char">367&#xA0;&#xB1;&#xA0;11</td><td char="&#xB1;" align="char">360&#xA0;&#xB1;&#xA0;23</td><td char="&#xB1;" align="char">365&#xA0;&#xB1;&#xA0;22</td><td char="&#xB1;" align="char">377&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">365&#xA0;&#xB1;&#xA0;20</td><td char="&#xB1;" align="char">361&#xA0;&#xB1;&#xA0;24</td></tr><tr><td align="left">IPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">357&#xA0;&#xB1;&#xA0;31</td><td char="&#xB1;" align="char">355&#xA0;&#xB1;&#xA0;32</td><td char="&#xB1;" align="char">276&#xA0;&#xB1;&#xA0;73</td><td char="&#xB1;" align="char">323&#xA0;&#xB1;&#xA0;47</td><td char="&#xB1;" align="char">324&#xA0;&#xB1;&#xA0;47</td><td char="&#xB1;" align="char">357&#xA0;&#xB1;&#xA0;20</td></tr><tr><td align="left">MPC</td><td char="&#xB1;" align="char">367&#xA0;&#xB1;&#xA0;30</td><td char="&#xB1;" align="char">349&#xA0;&#xB1;&#xA0;28</td><td char="&#xB1;" align="char">383&#xA0;&#xB1;&#xA0;28</td><td char="&#xB1;" align="char">383&#xA0;&#xB1;&#xA0;28</td><td char="&#xB1;" align="char">383&#xA0;&#xB1;&#xA0;28</td><td char="&#xB1;" align="char">382&#xA0;&#xB1;&#xA0;30</td></tr><tr><td align="left">MPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">346&#xA0;&#xB1;&#xA0;28</td><td char="&#xB1;" align="char">333&#xA0;&#xB1;&#xA0;34</td><td char="&#xB1;" align="char">248&#xA0;&#xB1;&#xA0;215</td><td char="&#xB1;" align="char">283&#xA0;&#xB1;&#xA0;142</td><td char="&#xB1;" align="char">375&#xA0;&#xB1;&#xA0;24</td><td char="&#xB1;" align="char">372&#xA0;&#xB1;&#xA0;17</td></tr><tr><td align="left">Pax</td><td char="&#xB1;" align="char">336&#xA0;&#xB1;&#xA0;25</td><td char="&#xB1;" align="char">280&#xA0;&#xB1;&#xA0;29*</td><td char="&#xB1;" align="char">236&#xA0;&#xB1;&#xA0;126</td><td char="&#xB1;" align="char">342&#xA0;&#xB1;&#xA0;71</td><td char="&#xB1;" align="char">343&#xA0;&#xB1;&#xA0;69</td><td char="&#xB1;" align="char">344&#xA0;&#xB1;&#xA0;68</td></tr><tr><td align="left" colspan="7"><italic>LVEDP (mmHg)</italic></td></tr><tr><td align="left">Control</td><td char="&#xB1;" align="char">12&#xA0;&#xB1;&#xA0;32</td><td char="&#xB1;" align="char">12&#xA0;&#xB1;&#xA0;5</td><td char="&#xB1;" align="char">53&#xA0;&#xB1;&#xA0;22<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">35&#xA0;&#xB1;&#xA0;15<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">26&#xA0;&#xB1;&#xA0;10</td><td char="&#xB1;" align="char">19&#xA0;&#xB1;&#xA0;7</td></tr><tr><td align="left">IPC</td><td char="&#xB1;" align="char">11&#xA0;&#xB1;&#xA0;1</td><td char="&#xB1;" align="char">4&#xA0;&#xB1;&#xA0;4</td><td char="&#xB1;" align="char">52&#xA0;&#xB1;&#xA0;22<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">24&#xA0;&#xB1;&#xA0;13</td><td char="&#xB1;" align="char">19&#xA0;&#xB1;&#xA0;8</td><td char="&#xB1;" align="char">18&#xA0;&#xB1;&#xA0;7</td></tr><tr><td align="left">IPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">14&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">11&#xA0;&#xB1;&#xA0;11</td><td char="&#xB1;" align="char">62&#xA0;&#xB1;&#xA0;22<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">56&#xA0;&#xB1;&#xA0;32<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">45&#xA0;&#xB1;&#xA0;33<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">28&#xA0;&#xB1;&#xA0;18</td></tr><tr><td align="left">MPC</td><td char="&#xB1;" align="char">12&#xA0;&#xB1;&#xA0;3</td><td char="&#xB1;" align="char">15&#xA0;&#xB1;&#xA0;5</td><td char="&#xB1;" align="char">51&#xA0;&#xB1;&#xA0;6<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">36&#xA0;&#xB1;&#xA0;7<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">29&#xA0;&#xB1;&#xA0;6</td><td char="&#xB1;" align="char">24&#xA0;&#xB1;&#xA0;7</td></tr><tr><td align="left">MPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">13&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">12&#xA0;&#xB1;&#xA0;4</td><td char="&#xB1;" align="char">57&#xA0;&#xB1;&#xA0;23<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">43&#xA0;&#xB1;&#xA0;24<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">38&#xA0;&#xB1;&#xA0;31</td><td char="&#xB1;" align="char">34&#xA0;&#xB1;&#xA0;34</td></tr><tr><td align="left">Pax</td><td char="&#xB1;" align="char">11&#xA0;&#xB1;&#xA0;5</td><td char="&#xB1;" align="char">8&#xA0;&#xB1;&#xA0;4</td><td char="&#xB1;" align="char">43&#xA0;&#xB1;&#xA0;17<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">23&#xA0;&#xB1;&#xA0;10</td><td char="&#xB1;" align="char">21&#xA0;&#xB1;&#xA0;8</td><td char="&#xB1;" align="char">20&#xA0;&#xB1;&#xA0;9</td></tr><tr><td align="left" colspan="7"><italic>dP/dt</italic><sub><italic>max</italic></sub><italic>(mmHg&#xA0;&#xB7;&#xA0;sec</italic><sup><italic>&#x2212;1</italic></sup><italic> 1,000)</italic></td></tr><tr><td align="left">Control</td><td char="&#xB1;" align="char">3.3&#xA0;&#xB1;&#xA0;0.6</td><td char="&#xB1;" align="char">3.3&#xA0;&#xB1;&#xA0;0.6</td><td char="&#xB1;" align="char">0.7&#xA0;&#xB1;&#xA0;0.9<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.6&#xA0;&#xB1;&#xA0;0.8<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.6&#xA0;&#xB1;&#xA0;0.7<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.4&#xA0;&#xB1;&#xA0;0.5<sup>&#x2020;</sup></td></tr><tr><td align="left">IPC</td><td char="&#xB1;" align="char">3.4&#xA0;&#xB1;&#xA0;1.1</td><td char="&#xB1;" align="char">3.5&#xA0;&#xB1;&#xA0;1.1</td><td char="&#xB1;" align="char">0.7&#xA0;&#xB1;&#xA0;1.0<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">1.4&#xA0;&#xB1;&#xA0;0.7<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">1.6&#xA0;&#xB1;&#xA0;0.5*,<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">1.5&#xA0;&#xB1;&#xA0;0.6*,<sup>&#x2020;</sup></td></tr><tr><td align="left">IPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">3.3&#xA0;&#xB1;&#xA0;0.4</td><td char="&#xB1;" align="char">2.7&#xA0;&#xB1;&#xA0;0.2</td><td char="&#xB1;" align="char">0.1&#xA0;&#xB1;&#xA0;0.1<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.3&#xA0;&#xB1;&#xA0;0.2<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.2&#xA0;&#xB1;&#xA0;0.1<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.1&#xA0;&#xB1;&#xA0;0.1<sup>&#x2020;</sup></td></tr><tr><td align="left">MPC</td><td char="&#xB1;" align="char">3.0&#xA0;&#xB1;&#xA0;0.4</td><td char="&#xB1;" align="char">2.7&#xA0;&#xB1;&#xA0;0.6</td><td char="&#xB1;" align="char">0.8&#xA0;&#xB1;&#xA0;0.4<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">1.0&#xA0;&#xB1;&#xA0;0.4<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">1.0&#xA0;&#xB1;&#xA0;0.3<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">1.0&#xA0;&#xB1;&#xA0;0.1*,<sup>&#x2020;</sup></td></tr><tr><td align="left">MPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">2.6&#xA0;&#xB1;&#xA0;0.5</td><td char="&#xB1;" align="char">2.5&#xA0;&#xB1;&#xA0;0.5</td><td char="&#xB1;" align="char">0.1&#xA0;&#xB1;&#xA0;0.1<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.3&#xA0;&#xB1;&#xA0;0.2<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.4&#xA0;&#xB1;&#xA0;0.3<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.3&#xA0;&#xB1;&#xA0;0.2<sup>&#x2020;</sup></td></tr><tr><td align="left">Pax</td><td char="&#xB1;" align="char">3.5&#xA0;&#xB1;&#xA0;1.1</td><td char="&#xB1;" align="char">3.0&#xA0;&#xB1;&#xA0;1.4</td><td char="&#xB1;" align="char">0.2&#xA0;&#xB1;&#xA0;0.1<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.4&#xA0;&#xB1;&#xA0;0.3<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.5&#xA0;&#xB1;&#xA0;0.4<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">0.5&#xA0;&#xB1;&#xA0;0.3<sup>&#x2020;</sup></td></tr><tr><td align="left" colspan="7"><italic>CF (mL&#xA0;&#xB7;&#xA0;min</italic><sup><italic>&#x2212;1</italic></sup><italic>)</italic></td></tr><tr><td align="left">Control</td><td char="&#xB1;" align="char">16&#xA0;&#xB1;&#xA0;3</td><td char="&#xB1;" align="char">15&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">9&#xA0;&#xB1;&#xA0;6<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">7&#xA0;&#xB1;&#xA0;6<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">7&#xA0;&#xB1;&#xA0;5<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">7&#xA0;&#xB1;&#xA0;6<sup>&#x2020;</sup></td></tr><tr><td align="left">IPC</td><td char="&#xB1;" align="char">14&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">11&#xA0;&#xB1;&#xA0;5</td><td char="&#xB1;" align="char">7&#xA0;&#xB1;&#xA0;4<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">11&#xA0;&#xB1;&#xA0;6</td><td char="&#xB1;" align="char">8&#xA0;&#xB1;&#xA0;6</td><td char="&#xB1;" align="char">9&#xA0;&#xB1;&#xA0;6</td></tr><tr><td align="left">IPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">13&#xA0;&#xB1;&#xA0;1</td><td char="&#xB1;" align="char">12&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">11&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">5&#xA0;&#xB1;&#xA0;2<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">4&#xA0;&#xB1;&#xA0;2<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">4&#xA0;&#xB1;&#xA0;4<sup>&#x2020;</sup></td></tr><tr><td align="left">MPC</td><td char="&#xB1;" align="char">16&#xA0;&#xB1;&#xA0;4</td><td char="&#xB1;" align="char">15&#xA0;&#xB1;&#xA0;4</td><td char="&#xB1;" align="char">9&#xA0;&#xB1;&#xA0;5<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">6&#xA0;&#xB1;&#xA0;3<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">5&#xA0;&#xB1;&#xA0;2<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">4&#xA0;&#xB1;&#xA0;2<sup>&#x2020;</sup></td></tr><tr><td align="left">MPC&#xA0;+&#xA0;Pax</td><td char="&#xB1;" align="char">15&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">14&#xA0;&#xB1;&#xA0;2</td><td char="&#xB1;" align="char">13&#xA0;&#xB1;&#xA0;4</td><td char="&#xB1;" align="char">8&#xA0;&#xB1;&#xA0;3<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">7&#xA0;&#xB1;&#xA0;4<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">6&#xA0;&#xB1;&#xA0;4<sup>&#x2020;</sup></td></tr><tr><td align="left">Pax</td><td char="&#xB1;" align="char">14&#xA0;&#xB1;&#xA0;1</td><td char="&#xB1;" align="char">10&#xA0;&#xB1;&#xA0;2*,<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">4&#xA0;&#xB1;&#xA0;2<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">4&#xA0;&#xB1;&#xA0;2<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">3&#xA0;&#xB1;&#xA0;1<sup>&#x2020;</sup></td><td char="&#xB1;" align="char">2&#xA0;&#xB1;&#xA0;1<sup>&#x2020;</sup></td></tr></tbody></table><table-wrap-foot><p>Data are mean&#xA0;&#xB1;&#xA0;SD</p><p>IPC&#xA0;=&#xA0;ischemic preconditioning; MPC&#xA0;=&#xA0;morphine preconditioning; Pax&#xA0;=&#xA0;paxilline</p><p>LVEDP&#xA0;=&#xA0;left ventricular end-diastolic pressure; dP/dt<sub>max</sub>&#xA0;=&#xA0;rate of left ventricular pressure development; CF&#xA0;=&#xA0;coronary flow; *<italic>&#xA0;P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> Control; <sup>&#x2020;</sup>&#xA0;<italic>P</italic>&#xA0;&lt;&#xA0;0.05 <italic>vs</italic> Baseline</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Discussion</title>
      <p>The main finding of our study is that the opioid, morphine, initiates preconditioning in a similar manner as ischemia, i.e., by activation of mK<sub>Ca</sub> channels.</p>
      <p>Ischemic preconditioning (IPC) describes a cardioprotective phenomenon where short periods of myocardial ischemia protect the heart against a subsequent longer period of ischemia and reduce the deleterious consequences of ischemia/reperfusion injury.<xref ref-type="bibr" rid="CR14">14</xref> Besides ischemic stimuli, volatile anesthetics<xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref> and morphine can mimic the cardioprotective effect of preconditioning.<xref ref-type="bibr" rid="CR17">17</xref> In contrast to volatile anesthetics, morphine can be administered to patients who are subjected to organ ischemia (vascular surgery, organ transplantation, cardiac surgery) or who recently underwent regional ischemia (stroke, angina pectoris, myocardial infarction, organ transplantation) without the side effect of being &#x201C;anesthetized&#x201D;. The mechanisms by which opioids protect the myocardium share common pathways with ischemic preconditioning. Opening of mitochondrial ATP-sensitive potassium (mK<sub>ATP</sub>) channels that are involved in regulating mitochondrial functions is a key step that mediates cardioprotection induced by both morphine and ischemic preconditioning, possibly through inhibition of mitochondrial permeability transition pore (mPTP) opening.<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR5">5</xref></p>
      <p>Mitochondrial calcium sensitive potassium (mK<sub>Ca</sub>) channels seem to be another class of K<sup>+</sup> channels, apart from mK<sub>ATP</sub> channels, that mediate cardioprotection by preconditioning.<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref> In 2002, Xu <italic>et al</italic>.<xref ref-type="bibr" rid="CR7">7</xref> reported that K<sub>Ca</sub>-activated potassium channels are located on the inner mitochondrial membrane and mediate cardioprotection against ischemia and reperfusion injury in the isolated perfused guinea pig heart. Since this initial observation, mK<sub>Ca</sub>-activated potassium channels have been found to be implicated in ischemic preconditioning against ischemia and reperfusion injury in isolated rat and mouse hearts, anesthetized dogs, and isolated cardiac myocytes.<xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></p>
      <p>The mK<sub>Ca</sub> channel contains a pore forming &#x3B1;-subunit and a regulatory &#x3B2;-subunit.<xref ref-type="bibr" rid="CR20">20</xref>-<xref ref-type="bibr" rid="CR22">22</xref> The &#x3B2;-subunit consists of four accessory &#x3B2;-subunits (&#x3B2;1-4). Both mK<sub>ATP</sub> and mK<sub>Ca</sub> channel activation triggers preconditioning that is independent one from the other and involves the mPTP. <xref ref-type="bibr" rid="CR8">8</xref> Cao <italic>et al.</italic> showed that ischemic preconditioning is triggered by activation of mK<sub>Ca</sub> channels and is abolished by the mK<sub>Ca</sub> channel inhibitor, paxilline.<xref ref-type="bibr" rid="CR8">8</xref> Paxilline is a mycotoxin produced by the fungus, <italic>Penicillium paxilli</italic>. It has the ability to block all subunits<xref ref-type="bibr" rid="CR23">23</xref> of mK<sub>Ca</sub> channels and is a selective inhibitor.<xref ref-type="bibr" rid="CR24">24</xref> Besides paxilline, there are not many mK<sub>Ca</sub> channel blockers available. Iberiotoxin, for example, is a mK<sub>Ca</sub> channel blocker that is also suitable for <italic>in vivo</italic> use,<xref ref-type="bibr" rid="CR13">13</xref> whereas paxilline is predominantly used for <italic>in vitro</italic> experiments. However, we did not check whether iberiotoxin also abolishes morphine preconditioning. Besides ischemic preconditioning, our results demonstrate that pharmacological preconditioning with morphine also induces cardioprotection by activation of mK<sub>Ca</sub> channels. Cao <italic>et al</italic>.<xref ref-type="bibr" rid="CR8">8</xref> administered the mK<sub>Ca</sub> channel blocker, paxilline, at the onset of reperfusion after a prolonged period of ischemia. We applied paxilline during the preconditioning period, suggesting that mK<sub>Ca</sub> channel inhibition blocks the infarct size reducing effect of preconditioning during the trigger phase. In a recent study, we could demonstrate that activation of mK<sub>Ca</sub> channels not only reduced infarct size by preconditioning but also caused a significant reduction in the mitochondrial respiratory control index.<xref ref-type="bibr" rid="CR13">13</xref> Co-administration of the mK<sub>Ca</sub> channel blocker, iberiotoxin, completely abolished the reduction in the respiratory control index, and we concluded that cardioprotection is mediated by activation of mK<sub>Ca</sub> channels leading to mild mitochondrial uncoupling. Mild mitochondrial uncoupling during the trigger phase of preconditioning may represent a common characteristic of mitochondria in a &#x201C;conditioned&#x201D; state.<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR25">25</xref>-<xref ref-type="bibr" rid="CR27">27</xref> The involvement of mK<sub>Ca</sub> channels in morphine-induced preconditioning was addressed in our study.</p>
      <p>We demonstrated here that ischemic- and morphine-induced preconditioning reduced the infarct size to a similar extent. The mK<sub>Ca</sub> channel blocker, paxilline, abolished both effects, confirming the findings of others that ischemic preconditioning involves activation of mK<sub>Ca</sub> channels. Furthermore, it supports our hypothesis that mK<sub>Ca</sub> channels are involved in the trigger phase of morphine-induced preconditioning. Heinen <italic>et al.</italic> showed that opening of mK<sub>Ca</sub> channels can cause a slight increase in mitochondrial reactive oxygen species generation.<xref ref-type="bibr" rid="CR28">28</xref> The mK<sub>Ca</sub> channel agonist, NS1619, requires superoxide radical generation during the preconditioning stimulus to induce a cardioprotective effect.<xref ref-type="bibr" rid="CR29">29</xref> Furthermore, these authors demonstrated that cardioprotection by NS1619 reduces mitochondrial calcium overload and mitochondrial reactive oxygen species production during the subsequent period of ischemia and early reperfusion.<xref ref-type="bibr" rid="CR29">29</xref> Such a reduction in mitochondrial calcium overload and reactive oxygen species generation has been suggested to prevent mPTP opening.<xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref> Evidence suggests that the mK<sub>Ca</sub> channel is located upstream of the mPTP, because cardioprotection induced by activation of mK<sub>Ca</sub> channels was abolished by opening of the mPTP. Vice versa, inhibition of the mK<sub>Ca</sub> channel with paxilline did not block protection induced by inhibition of the mPTP with cyclosporine A (CsA).<xref ref-type="bibr" rid="CR8">8</xref> Whether cardiac preconditioning by morphine is also mediated by regulation of the mPTP due to mK<sub>Ca</sub> channel activation is yet unknown.</p>
      <p>The results of the present study have to be interpreted within the scope of some limitations. First, we did not investigate possible upstream mechanisms of mK<sub>Ca</sub> channels. Opioid receptors are G-protein coupled receptors whose activation inhibits adenylyl cyclase. The post-receptor signalling following opioid receptor activation has not been well defined. We cannot rule out that morphine confers preconditioning via intracellular pathways leading to activation of mK<sub>Ca</sub> channels. However, the means by which morphine regulates mK<sub>Ca</sub> channel activation to induce preconditioning is unknown. It has been shown that mK<sub>Ca</sub> channel activation is involved in desflurane preconditioning and that protein kinase A (PKA) is located upstream of the mK<sub>Ca</sub> channel.<xref ref-type="bibr" rid="CR32">32</xref> The activity of PKA as a possible upstream activator of K<sub>Ca</sub> channels depends on the cellular level of cyclic adenosine monophosphate (cAMP)&#x2014;PKA is known as cAMP-dependent protein kinase. Gross <italic>et al.</italic> demonstrated that morphine-induced cardioprotection involves glycogen synthase kinase-3beta (GSK3beta) and Akt (also called PKB).<xref ref-type="bibr" rid="CR33">33</xref> However, we did not investigate in the present study whether these enzymes are related to mK<sub>Ca</sub> channels.</p>
      <p>Another limitation of our study is that we did not determine the effect of ischemic and morphine preconditioning on the mitochondria. Xi <italic>et al.</italic> could show that morphine prevents mPTP opening by inactivation of GSK3beta.<xref ref-type="bibr" rid="CR34">34</xref> Our results showing that morphine confers preconditioning through activation of mK<sub>Ca</sub> channels and the fact that enzymes like PKA regulate mK<sub>Ca</sub> channel activation suggest future directions for investigating the underlying mechanism of morphine-induced cardioprotection. Clinically, morphine might be administered to patients who are subjected to organ ischemia (vascular surgery, organ transplantation, cardiac surgery) or who recently underwent regional ischemia (stroke, angina pectoris, myocardial infarction, organ transplantation) without the side-effect of being &#x201C;anesthetized&#x201D;. Furthermore, there is no &#x3BA;-opioid agonist for clinical practice available. Therefore, unravelling the exact mechanisms of morphine-induced cardioprotection might have clinical consequences.</p>
      <p>In summary, our results demonstrate that, besides ischemic preconditioning, morphine also initiates cardiac preconditioning via activation of mK<sub>Ca</sub> channels.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p><bold>Financial support</bold> This study was supported by institutional and departmental sources. This work is part of Corinna Niersmann&#x2019;s MD thesis.</p>
      <p><bold>Conflicts of interest</bold> None declared.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferdinandy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Baxter</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
          <article-title>Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning</article-title>
          <source>Pharmacol Rev</source>
          <year>2007</year>
          <volume>59</volume>
          <fpage>418</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="doi">10.1124/pr.107.06002</pub-id>
          <pub-id pub-id-type="pmid">18048761</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Role of opioids in acute and delayed preconditioning</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2003</year>
          <volume>35</volume>
          <fpage>709</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-2828(03)00135-4</pub-id>
          <pub-id pub-id-type="pmid">12818560</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>XM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Downey</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels</article-title>
          <source>Circ Res</source>
          <year>2001</year>
          <volume>89</volume>
          <fpage>273</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="doi">10.1161/hh1501.094266</pub-id>
          <pub-id pub-id-type="pmid">11485978</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hausenloy</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Maddock</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Baxter</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?</article-title>
          <source>Cardiovasc Res</source>
          <year>2002</year>
          <volume>55</volume>
          <fpage>534</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(02)00455-8</pub-id>
          <pub-id pub-id-type="pmid">12160950</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Steenbergen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Preconditioning: the mitochondrial connection</article-title>
          <source>Annu Rev Physiol</source>
          <year>2007</year>
          <volume>69</volume>
          <fpage>51</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.physiol.69.031905.163645</pub-id>
          <pub-id pub-id-type="pmid">17007587</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shintani</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Node</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Asanuma</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Opening of Ca2&#xA0;+&#xA0;-activated K&#xA0;+&#xA0;channels is involved in ischemic preconditioning in canine hearts</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2004</year>
          <volume>37</volume>
          <fpage>1213</fpage>
          <lpage>1218</lpage>
          <pub-id pub-id-type="pmid">15572051</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytoprotective role of Ca2&#xA0;+&#xA0;- activated K&#xA0;+&#xA0;channels in the cardiac inner mitochondrial membrane</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>298</volume>
          <fpage>1029</fpage>
          <lpage>1033</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1074360</pub-id>
          <pub-id pub-id-type="pmid">12411707</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2005</year>
          <volume>312</volume>
          <fpage>644</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="doi">10.1124/jpet.104.074476</pub-id>
          <pub-id pub-id-type="pmid">15345753</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>The K(Ca) channel as a trigger for the cardioprotection induced by kappa-opioid receptor stimulation&#x2013;its relationship with protein kinase C</article-title>
          <source>Br J Pharmacol</source>
          <year>2005</year>
          <volume>145</volume>
          <fpage>984</fpage>
          <lpage>991</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.bjp.0706268</pub-id>
          <pub-id pub-id-type="pmid">15912131</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Pharmacology of opioids</article-title>
          <source>Pharmacol Rev</source>
          <year>1983</year>
          <volume>35</volume>
          <fpage>283</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">6144112</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trescot</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians&#x2019; (ASIPP) Guidelines</article-title>
          <source>Pain Physician</source>
          <year>2008</year>
          <volume>11</volume>
          <fpage>S5</fpage>
          <lpage>S62</lpage>
          <pub-id pub-id-type="pmid">18443640</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels</article-title>
          <source>Circ Res</source>
          <year>1999</year>
          <volume>84</volume>
          <fpage>1396</fpage>
          <lpage>1400</lpage>
          <pub-id pub-id-type="pmid">10381891</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Huhn</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smeele</surname>
              <given-names>KM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Helium-induced preconditioning in young and old rat heart: impact of mitochondrial Ca(2&#xA0;+) -sensitive potassium channel activation</article-title>
          <source>Anesthesiology</source>
          <year>2008</year>
          <volume>109</volume>
          <fpage>830</fpage>
          <lpage>836</lpage>
          <pub-id pub-id-type="doi">10.1097/ALN.0b013e3181895aa0</pub-id>
          <pub-id pub-id-type="pmid">18946295</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murry</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Jennings</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Reimer</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium</article-title>
          <source>Circulation</source>
          <year>1986</year>
          <volume>74</volume>
          <fpage>1124</fpage>
          <lpage>1136</lpage>
          <pub-id pub-id-type="pmid">3769170</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cason</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Gamperl</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Slocum</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Hickey</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits</article-title>
          <source>Anesthesiology</source>
          <year>1997</year>
          <volume>87</volume>
          <fpage>1182</fpage>
          <lpage>1190</lpage>
          <pub-id pub-id-type="doi">10.1097/00000542-199711000-00023</pub-id>
          <pub-id pub-id-type="pmid">9366471</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mullenheim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ebel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Frassdorf</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Isoflurane preconditions myocardium against infarction via release of free radicals</article-title>
          <source>Anesthesiology</source>
          <year>2002</year>
          <volume>96</volume>
          <fpage>934</fpage>
          <lpage>940</lpage>
          <pub-id pub-id-type="doi">10.1097/00000542-200204000-00022</pub-id>
          <pub-id pub-id-type="pmid">11964602</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schultz</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart</article-title>
          <source>Circ Res</source>
          <year>1996</year>
          <volume>78</volume>
          <fpage>1100</fpage>
          <lpage>1104</lpage>
          <pub-id pub-id-type="pmid">8635241</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saegusa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nakaya</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial Ca2&#xA0;+&#xA0;-activated K&#xA0;+&#xA0;channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>111</volume>
          <fpage>198</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.0000151099.15706.B1</pub-id>
          <pub-id pub-id-type="pmid">15623543</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kukreja</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Opening of Ca2&#xA0;+&#xA0;-activated K&#xA0;+&#xA0;channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2004</year>
          <volume>287</volume>
          <fpage>H2070</fpage>
          <lpage>H2077</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00431.2004</pub-id>
          <pub-id pub-id-type="pmid">15217801</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaczorowski</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Leonard</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>McManus</surname>
              <given-names>OB</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>High-conductance calcium-activated potassium channels; structure, pharmacology, and function</article-title>
          <source>J Bioenerg Biomembr</source>
          <year>1996</year>
          <volume>28</volume>
          <fpage>255</fpage>
          <lpage>267</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02110699</pub-id>
          <pub-id pub-id-type="pmid">8807400</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munujos</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Knaus</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Kaczorowski</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Cross-linking of charybdotoxin to high-conductance calcium-activated potassium channels: identification of the covalently modified toxin residue</article-title>
          <source>Biochemistry</source>
          <year>1995</year>
          <volume>34</volume>
          <fpage>10771</fpage>
          <lpage>10776</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00034a009</pub-id>
          <pub-id pub-id-type="pmid">7545007</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meera</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ottolia</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of and modulation by a beta-subunit of a human maxi KCa channel cloned from myometrium</article-title>
          <source>Receptors Channels</source>
          <year>1995</year>
          <volume>3</volume>
          <fpage>185</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">8821792</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Chavoshy</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Presynaptic Ca2&#xA0;+&#xA0;-activated K&#xA0;+&#xA0;channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release</article-title>
          <source>J Neurosci</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>9585</fpage>
          <lpage>9597</lpage>
          <pub-id pub-id-type="pmid">11739569</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanchez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McManus</surname>
              <given-names>OB</given-names>
            </name>
          </person-group>
          <article-title>Paxilline inhibition of the alpha-subunit of the high-conductance calcium-activated potassium channel</article-title>
          <source>Neuropharmacology</source>
          <year>1996</year>
          <volume>35</volume>
          <fpage>963</fpage>
          <lpage>968</lpage>
          <pub-id pub-id-type="doi">10.1016/0028-3908(96)00137-2</pub-id>
          <pub-id pub-id-type="pmid">8938726</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liem</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Manintveld</surname>
              <given-names>OC</given-names>
            </name>
            <name>
              <surname>Schoonderwoerd</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischemic preconditioning modulates mitochondrial respiration, irrespective of the employed signal transduction pathway</article-title>
          <source>Transl Res</source>
          <year>2008</year>
          <volume>151</volume>
          <fpage>17</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1016/j.trsl.2007.09.007</pub-id>
          <pub-id pub-id-type="pmid">18061124</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ljubkovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mio</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Marinovic</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2007</year>
          <volume>292</volume>
          <fpage>C1583</fpage>
          <lpage>C1590</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpcell.00221.2006</pub-id>
          <pub-id pub-id-type="pmid">17215328</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minners</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lacerda</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ischemic and pharmacological preconditioning in Girardi cells and C2C12 myotubes induce mitochondrial uncoupling</article-title>
          <source>Circ Res</source>
          <year>2001</year>
          <volume>89</volume>
          <fpage>787</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="doi">10.1161/hh2101.098372</pub-id>
          <pub-id pub-id-type="pmid">11679408</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Camara</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Aldakkak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Ries</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Stowe</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial Ca2&#xA0;+&#xA0;-induced K&#xA0;+&#xA0;influx increases respiration and enhances ROS production while maintaining membrane potential</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2007</year>
          <volume>292</volume>
          <fpage>C148</fpage>
          <lpage>C156</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpcell.00215.2006</pub-id>
          <pub-id pub-id-type="pmid">16870831</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stowe</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Aldakkak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Camara</surname>
              <given-names>AK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiac mitochondrial preconditioning by Big Ca2&#xA0;+&#xA0;-sensitive K&#xA0;+&#xA0;channel opening requires superoxide radical generation</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2006</year>
          <volume>290</volume>
          <fpage>H434</fpage>
          <lpage>H440</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00763.2005</pub-id>
          <pub-id pub-id-type="pmid">16126810</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halestrap</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Khaliulin</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>The role of mitochondria in protection of the heart by preconditioning</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2007</year>
          <volume>1767</volume>
          <fpage>1007</fpage>
          <lpage>1031</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbabio.2007.05.008</pub-id>
          <pub-id pub-id-type="pmid">17631856</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hausenloy</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore</article-title>
          <source>Cardiovasc Res</source>
          <year>2007</year>
          <volume>75</volume>
          <fpage>530</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cardiores.2007.04.022</pub-id>
          <pub-id pub-id-type="pmid">17512507</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jazbutyte</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation of mitochondrial large-conductance calcium-activated K&#xA0;+&#xA0;channels via protein kinase A mediates desflurane-induced preconditioning</article-title>
          <source>Anesth Analg</source>
          <year>2008</year>
          <volume>106</volume>
          <fpage>384</fpage>
          <lpage>391</lpage>
          <pub-id pub-id-type="doi">10.1213/ane.0b013e318160650f</pub-id>
          <pub-id pub-id-type="pmid">18227289</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Gross</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2006</year>
          <volume>291</volume>
          <fpage>H827</fpage>
          <lpage>H834</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00003.2006</pub-id>
          <pub-id pub-id-type="pmid">16517948</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Morphine prevents the mitochondrial permeability transition pore opening through NO/cGMP/PKG/Zn2&#xA0;+/GSK-3beta signal pathway in cardiomyocytes</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2010</year>
          <volume>298</volume>
          <fpage>H601</fpage>
          <lpage>H607</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00453.2009</pub-id>
          <pub-id pub-id-type="pmid">19966058</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
